What age‑ and risk‑appropriate screening tests are recommended for adults?

Age- and Risk-Appropriate Screening Tests for Adults

For average-risk adults, begin colorectal cancer screening at age 45 years with either colonoscopy every 10 years or annual FIT (fecal immunochemical test), continue through age 75 years if life expectancy exceeds 10 years, and stop screening after age 75 years unless the patient has never been screened. 1, 2

Colorectal Cancer Screening: The Primary Focus

The evidence provided focuses predominantly on colorectal cancer (CRC) screening, which represents the most comprehensively studied and guideline-supported screening intervention for adults.

Starting Age: 45 vs. 50 Years

There is evolving consensus favoring earlier initiation:

• The American Cancer Society (2018) recommends starting at age 45 for all average-risk adults (qualified recommendation), with a strong recommendation for those aged 50 and older 1
• The USPSTF (2021) and NCCN (2024) now recommend screening beginning at age 45 based on microsimulation modeling showing efficient balance of benefits and colonoscopy burden 3, 2
• The U.S. Multi-Society Task Force maintains age 50 as the starting point for non-African American adults (strong recommendation), but suggests age 45 for African Americans (weak recommendation) 1

Clinical reasoning: Approximately 43% of early-onset CRC cases occur in individuals aged 45-49 years, and CRC incidence has increased by 1.9% annually in those under 50 since 2011 2. This epidemiologic shift justifies the lower starting age.

First-Tier Screening Options

Colonoscopy every 10 years or annual FIT are the recommended first-tier options (strong recommendation, moderate-quality evidence) 1:

• Colonoscopy offers both detection and removal of precancerous lesions
• Annual FIT provides a non-invasive alternative with good sensitivity for CRC

Alternative Screening Methods (Second-Tier)

For patients who refuse colonoscopy and FIT 1:

• CT colonography every 5 years (strong recommendation, low-quality evidence)
• FIT-fecal DNA every 3 years (strong recommendation, low-quality evidence)
• Flexible sigmoidoscopy every 5-10 years (strong recommendation, high-quality evidence)

Important caveat: FIT-fecal DNA has higher sensitivity (92% for CRC, 42% for adenomas) but lower specificity (84% for CRC, 87% for advanced adenomas), leading to more false-positives and unnecessary colonoscopies 1. CT colonography identifies extracolonic findings in 40-70% of examinations, with 5-37% requiring diagnostic follow-up but only 3% ultimately needing treatment 1.

Stopping Age: The Critical Decision Point

Discontinue screening at age 75 years in adults with prior negative screening or life expectancy less than 10 years 1:

• The average time to prevent 1 CRC death per 1,000 patients screened is 10.3 years 1
• Average life expectancy at age 75 is 9.9 years for men and 12 years for women 1
• Adults aged 70 with serious comorbidities have life expectancies of 8.9 years (men) and 10.8 years (women) 1

For ages 76-85: Individualize decisions based on:

• Prior screening history (never-screened individuals may still benefit)
• Overall health status
• Life expectancy
• Patient preferences 1

After age 85: Discourage continued screening (qualified recommendation) 1

Risk Stratification Considerations

African Americans: Consider starting at age 45 years (weak recommendation, very-low-quality evidence) 1

Family history of CRC: Screen at age 40 or 10 years before the age at diagnosis of the affected family member, whichever is earlier 3

Common Pitfalls to Avoid

1. Screening patients over 75 with prior negative results: Harms outweigh benefits due to increased complication rates with age and insufficient time to realize mortality benefit 1

2. Using Septin9 blood test: Not recommended (weak recommendation against) 1

3. Ignoring quality metrics: Physicians performing colonoscopy must measure adenoma detection rate; those performing FIT must monitor quality 1

4. Failing to follow up positive non-colonoscopy tests: All positive FIT, FIT-DNA, or CT colonography results require timely colonoscopy 1

5. Screening young adults (<45 years) without symptoms: Not recommended for average-risk individuals, but maintain high suspicion for alarm symptoms (iron deficiency anemia, rectal bleeding, change in bowel habits) as diagnostic delays are common in this age group 2

Algorithm for Implementation

Step 1: Determine patient age and risk category

• Average-risk: No personal/family history of CRC, adenomas, inflammatory bowel disease, or hereditary syndromes

Step 2: For ages 45-75 with life expectancy >10 years:

• Offer colonoscopy every 10 years OR annual FIT as first choice
• If refused, offer CT colonography (every 5 years), FIT-DNA (every 3 years), or flexible sigmoidoscopy (every 5-10 years)

Step 3: For ages 76-85:

• If never screened AND healthy: Consider screening
• If previously screened with negative results: Stop screening

Step 4: Age >85:

• Do not screen